Rentschler begins operation of single-use bioreactor in Massachusetts

The XDR-500 bioreactor installed at the CDMO site in Milford is planned to be client-ready in mid-2020

picture of

Breaking News

ARTeSYN expands Irish single-use biopharma equipment production

The $1.1m investment will be used to increase manufacturing and cleanroom facilities while adding 50 new jobs in the ...

Fujifilm plans major US gene therapy facility as part of $120m investment

The investment will include the construction of new cGMP facilities in the US to support CDMO services in the sector

GW Pharmaceuticals gains product recognition by NHS England

Epidyolex (cannabidiol) oral solution and Sativex (nabiximols) have been recommended for use by the UK’s National ...

CPhI Pharma Awards winners

Top innovators, performers and outstanding achievements have been recognised by global industry event

HVAC hire companies merge businesses

UK-based Cross Rental Services has acquired Swegon Hire UK, planning to phase out the brand and operating name in the ...

Report warns of inaction to remove residues from wastewater

Document by the OECD argues that because pharmaceuticals are designed to interact with living organisms at low doses, ...

Medical cannabis made in Italy

Dr Fabio Di Francesco, a compounding pharmacist based in Rome, describes how cannabis is used in medicinal formulations ...

US spinal implant manufacturer plans major cleanroom expansion

Nexxt Spine has purchased a new building and improvements include tripling 3D printing room size, a new dedicated test ...

Deviations and CAPAs are hot topics in GMP inspections

GMP experts at the ECA Academy comment on a warning letter issued to Glenmark by the FDA

CPhI 2019 Annual Report: The future of patient-centric CDMOs in the spotlight

Experts Peter Soelkner of Vetter Pharma, Stewart Needleman of Piramal Pharma Solutions, and Adam Bradbury, Industry ...

Cleanroom garments: Risk focus meets quality by design

A holistic approach for cleanroom garment validation spends more effort at the outset of design phase and on design ...

CPhI Annual Report foresees massive shortfalls in ATP production and bio capacity growth in China

A shortage of qualified personnel may be a drag factor in cell and gene therapies yet in China, 100,00L of capacity ...

Mesa Labs acquires Gyros Protein Technologies

The US-based quality control instrument supplier has acquired the Swedish protein synthesis solutions provider to begin ...

HTL ups GMP production capacity of injectable-grade sodium hyaluronate

The French facility will multiply HTL Biotechnology’s injectable-grade sodium hyaluronate production capacity by 2.5 ...